SUN PHARMACEUTICAL INDUSTRIES
|
|
BOM : 524715     NSE : SUNPHARMA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Aug 30,2024 |
Price(EOD): ₹ 1,820.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 436,852.55 Cr |
Sun Pharmaceutical Industries Limited is a leading global pharmaceutical company and the largest pharmaceutical entity in India. With a diverse portfolio including specialty medicines, branded generics, pure generics, and Active Pharmaceutical Ingredients (APIs), Sun Pharma op... Read More >
Industry Peers & Returns | 1W | 1M | 1Y |
SUN PHARMACEUTICAL INDUSTRIES | 2.7% | 6% | 62.4% |
CIPLA | 3.9% | 7.3% | 33.9% |
DR REDDYS LABORATORIES | 1.2% | 4.2% | 20.1% |
ZYDUS LIFESCIENCES | 1.8% | -9.5% | 80.1% |
DIVIS LABORATORIES | 3.2% | 3.5% | 37.8% |
MANKIND PHARMA | 5.6% | 22.5% | 35.8% |
FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF SUN PHARMACEUTICAL INDUSTRIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
41.58
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 10,506.70 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 6.86
P/B Calculated based on Book Value of Rs 63,666.80 Cr
[Latest Year - Mar2024 - Consolidated Results ] 8.88
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 49,208.80 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
82% 24% 20% |
SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES
SUN PHARMACEUTICAL INDUSTRIES vs SENSEX
DEBT OF SUN PHARMACEUTICAL INDUSTRIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0.47 0.32 0.2 0.33 |
0.04 0.11 0.02 0.06 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF SUN PHARMACEUTICAL INDUSTRIES
Pledged Promoter Shares |
2.44 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF SUN PHARMACEUTICAL INDUSTRIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
5.59% 18.86% 21.59% 7.67% |
5.96% 8.35% 37.98% 42.63% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
SUN PHARMACEUTICAL INDUSTRIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.5% | 7.5% | 54.8% |
S&P BSE SENSEX50 | 1.6% | 1.6% | 30.5% |
S&P BSE SENSEX | 1.6% | 1.1% | 26.2% |
S&P BSE 100 | 1.5% | 1.5% | 34.6% |
S&P BSE CARBONEX | 1.5% | 1.4% | 34.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY PHARMA | 3.1% | 7.8% | 52.8% |
NIFTY HEALTHCARE | 2.9% | 6.5% | 52% |
NIFTY50 EQUAL WEIGHT | 1.9% | 2.2% | 42.3% |
NIFTY 50 | 1.7% | 1.5% | 30.2% |
NIFTY 100 | 1.4% | 1.4% | 36% |
You may also like the below Video Courses
FAQ about SUN PHARMACEUTICAL INDUSTRIES
Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?
As on Aug 30,2024, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?
As on Aug 30,2024, SUN PHARMACEUTICAL INDUSTRIES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?
As on Aug 30,2024, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,468.52 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,001.88
Fair Value [Median EV / Sales Model] : Rs. 1,468.52
Fair Value [Median Price / Sales Model] : Rs. 1,511.49
Estimated Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,468.52
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.